Within the PREDiCT series, Tumor Models San Francisco stands out as the primary platform for Immuno-Oncology research. Offering tailored insights for the unique field, as well the opportunity to debate the niche topics that are currently hot within the field right now.

This summit is dedicated to scientists trying to select the right IO candidates, improve the efficiency with which they advance through preclinical trials without compromising safety, and more accurately translate from murine models into humans using both current and more novel technologies.